1. Home
  2. MGLD vs OMGA Comparison

MGLD vs OMGA Comparison

Compare MGLD & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • OMGA
  • Stock Information
  • Founded
  • MGLD 1996
  • OMGA 2017
  • Country
  • MGLD United States
  • OMGA United States
  • Employees
  • MGLD N/A
  • OMGA N/A
  • Industry
  • MGLD Finance/Investors Services
  • OMGA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGLD Finance
  • OMGA Health Care
  • Exchange
  • MGLD Nasdaq
  • OMGA Nasdaq
  • Market Cap
  • MGLD 59.9M
  • OMGA 53.6M
  • IPO Year
  • MGLD N/A
  • OMGA 2021
  • Fundamental
  • Price
  • MGLD $1.50
  • OMGA $0.89
  • Analyst Decision
  • MGLD
  • OMGA Strong Buy
  • Analyst Count
  • MGLD 0
  • OMGA 5
  • Target Price
  • MGLD N/A
  • OMGA $9.20
  • AVG Volume (30 Days)
  • MGLD 11.1K
  • OMGA 256.8K
  • Earning Date
  • MGLD 02-12-2025
  • OMGA 11-14-2024
  • Dividend Yield
  • MGLD N/A
  • OMGA N/A
  • EPS Growth
  • MGLD N/A
  • OMGA N/A
  • EPS
  • MGLD N/A
  • OMGA N/A
  • Revenue
  • MGLD $32,511,000.00
  • OMGA $8,095,000.00
  • Revenue This Year
  • MGLD N/A
  • OMGA $181.29
  • Revenue Next Year
  • MGLD N/A
  • OMGA N/A
  • P/E Ratio
  • MGLD N/A
  • OMGA N/A
  • Revenue Growth
  • MGLD N/A
  • OMGA 185.04
  • 52 Week Low
  • MGLD $0.78
  • OMGA $0.75
  • 52 Week High
  • MGLD $1.92
  • OMGA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 54.48
  • OMGA 45.10
  • Support Level
  • MGLD $1.32
  • OMGA $0.83
  • Resistance Level
  • MGLD $1.58
  • OMGA $1.02
  • Average True Range (ATR)
  • MGLD 0.13
  • OMGA 0.10
  • MACD
  • MGLD 0.01
  • OMGA 0.01
  • Stochastic Oscillator
  • MGLD 75.42
  • OMGA 42.31

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About OMGA Omega Therapeutics Inc.

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.

Share on Social Networks: